The severity and prognosis of exacerbated inflammatory responses in conditions like cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), hemorrhagic stroke, and sepsis within the context of COVID-19 pneumonia have been notably associated with CRP. This evidence concerns the gene CRP and cardiovascular disorder.